ISTAR MEDICAL
The computed 12-month bankruptcy probability of ISTAR MEDICAL is 0.1% (very low). The company has been active since 2010 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
| Active | 16 yrs |
| Board | 12 |
| Locations | 1 |
| Publications | 37 |
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
| Fiscal year | Type | Filed | Reference |
|---|---|---|---|
| 31-12-2024 | volledig | 24-09-2025 | 2025-00503698 |
| 31-12-2023 | volledig | 09-08-2024 | 2024-00341075 |
| 31-12-2022 | volledig | 05-09-2023 | 2023-00443685 |
| 31-12-2021 | volledig | 27-07-2022 | 2022-20266246 |
| 31-12-2020 | volledig | 06-07-2021 | 2021-31400444 |
| 31-12-2019 | volledig | 22-07-2020 | 2020-32400586 |
| 31-12-2018 | volledig | 20-06-2019 | 2019-19900215 |
| 31-12-2017 | volledig | 21-06-2018 | 2018-20500095 |
| 31-12-2016 | volledig | 26-07-2017 | 2017-36700415 |
| 31-12-2015 | volledig | 25-07-2016 | 2016-35500115 |
-
MV Lifesciences SRLLegal entityManaging director· perm. rep.: Michel VanbrabantState Gazette act 24139544 (26-09-2024)Current26-09-2024 → present
-
Current16-04-2024 → present
-
MV LifesciencesLegal entityDirector· perm. rep.: VANBRABANT MichelState Gazette act 25363761 (17-10-2025)Current01-01-2024 → present
-
Capricorn Partners NVLegal entityDirector· perm. rep.: Filip PintelonState Gazette act 24139544 (26-09-2024)Current31-07-2023 → present
2 events
- 26-09-2024 Mandate renewed· Director
- 31-07-2023 Mandate renewed· Director
-
Mel Management srlLegal entityDirector· perm. rep.: Michel LussierState Gazette act 23098607 (31-07-2023)Current31-07-2023 → present
-
Current01-01-2023 → present
Show 6 more sitting directors
-
Current02-09-2019 → present
2 events
- 31-07-2023 Mandate renewed· Director
- 02-09-2019 Appointed· Director
-
Current02-09-2019 → present
2 events
- 31-07-2023 Mandate renewed· Director
- 02-09-2019 Mandate renewed· Director
-
Current02-09-2019 → present
2 events
- 31-07-2023 Mandate renewed· Director
- 02-09-2019 Appointed· Director
-
Current02-09-2019 → present
2 events
- 31-07-2023 Mandate renewed· Director
- 02-09-2019 Mandate renewed· Director
-
Current31-07-2019 → present
2 events
- 29-09-2025 Appointed· Managing director
- 31-07-2019 Appointed· Managing director
-
Current15-04-2016 → present
3 events
- 31-07-2023 Mandate renewed· Director
- 02-09-2019 Mandate renewed· Director
- 15-04-2016 Mandate renewed· Director
Historic, not recently confirmed (9)
-
Not recently confirmedlast confirmed in an act from 2019
-
Capricorn Venture Partners NVLegal entityDirector· perm. rep.: Ekaterina SmirnyaginaState Gazette act 19117454 (02-09-2019)Not recently confirmedlast confirmed in an act from 2019
3 events
- 02-09-2019 Mandate renewed· Director
- 01-06-2016 Appointed· Director
- 15-04-2016 Mandate renewed· Director
-
Mel Management SPRLLegal entityDirector· perm. rep.: Michel LussierState Gazette act 19117454 (02-09-2019)Not recently confirmedlast confirmed in an act from 2019
2 events
- 02-09-2019 Mandate renewed· Director
- 01-01-2018 Appointed· Director
-
New Breath SPRLLegal entityDirector· perm. rep.: Michel VanbrabantState Gazette act 19117454 (02-09-2019)Not recently confirmedlast confirmed in an act from 2019
4 events
- 02-09-2019 Mandate renewed· Director
- 01-06-2016 Appointed· Director
- 15-04-2016 Mandate renewed· Director
- 15-04-2016 Mandate renewed· Managing director
-
Not recently confirmedlast confirmed in an act from 2017
-
Not recently confirmedlast confirmed in an act from 2016
-
Sparaxis SALegal entityDirector· perm. rep.: Philippe DegiveState Gazette act 16160390 (23-11-2016)Not recently confirmedlast confirmed in an act from 2016
2 events
- 01-06-2016 Appointed· Director
- 15-04-2016 Mandate renewed· Director
-
Not recently confirmedlast confirmed in an act from 2016
-
Not recently confirmedlast confirmed in an act from 2013
Permanent representatives (1)
-
Mel Management SPRLLegal entityPermanent representative· perm. rep.: Michel LussierState Gazette act 20014621 (24-01-2020)Permanent representative31-07-2019 → present
Former directors (3)
-
MEL MANAGEMENTLegal entityDirector· perm. rep.: Michel LussierState Gazette act 24061841 (16-04-2024)Former- → 25-01-2024
-
Medpole SALegal entityDirector· perm. rep.: Michel LussierState Gazette act 16053139 (15-04-2016)Former15-04-2016 → 31-12-2017
2 events
- 31-12-2017 Resigned· Director
- 15-04-2016 Mandate renewed· Director
-
Former20-07-2010 → 16-07-2014
6 events
- 16-07-2014 Resigned· Director
- 16-07-2014 Resigned· Managing director
- 16-07-2014 Resigned· Managing director
- 08-01-2014 Appointed· Gestion journalière
- 15-11-2013 Appointed· Director
- 20-07-2010 Appointed· Managing director
| Statutory auditor | IRE/IBR number | Tenure |
|---|---|---|
| PwC Réviseurs d'Entreprises SRLCurrent Statutory auditor · represented by Patrick Mort |
- | 16-02-2022 → present |
Show 2 earlier auditors
| PricewaterhouseCoopers Reviseurs d'Entreprises Statutory auditor · represented by Mélanie Adorante succeeded by PwC Réviseurs d'Entreprises SRL in 2022 |
- | 07-12-2020 → 16-02-2022 |
| SCCRL PwC Réviseurs d'Entreprises Statutory auditor · represented by Mélanie Adorante succeeded by PricewaterhouseCoopers Reviseurs d'Entreprises in 2020 |
- | 01-12-2014 → 07-12-2020 |
| NACE primary | Activiteiten van medische beeldvorming en medische laboratoria(86910) |
| Legal form | Public limited company(014) |
| Incorporation | 20-07-2010 |
| Status | Active |
| Postal code | 1300 |
Each band states what its claims rest on. A board seat is influence over the board, not ownership. Court mandates (receiver, interim administrator) and liquidation mandates do not link companies and are therefore absent here; they belong under Directors & mandates.
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 25112C0103/00A000 | Wallonia | 6,046 m² | 1 · 967 m² | - |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
Of the 37 Belgian State Gazette acts we know for this company, 36 have been read. The other one has not been read yet: what they contain is neither established nor disproved here.
30-06-2026 Act object · Notarial deed · General meeting · Capital increase
- Act object: CAPITAL, ACTIONS, STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS) · ISTAR MEDICAL
- Publication: 30/06/2026 · ISTAR MEDICAL
- Filing: 26-06-2026 · ISTAR MEDICAL
- Notarial deed: 19/06/2026 · ISTAR MEDICAL
- General meeting: 19/06/2026 · ISTAR MEDICAL
- Capital increase: after: 84.277.306,56 EUR, delta: 1.500.000,00 EUR, amount: 84277306.56, before: 82.777.306,56 EUR, paid_up: 100%, currency: EUR, shares_issued: 44.117 Actions Privilégiées de Classe D, price_per_share: 34,00 EUR · ISTAR MEDICAL
- Share issue: type: droits de souscription de classe D, count: 88.234 · ISTAR MEDICAL
- Capital: amount: 84277306.56, shares: 2.268.948, currency: EUR · ISTAR MEDICAL
- Statute amendment: Remplacement de l'article 5 des statuts pour mettre en concordance avec les résolutions prises (capital et répartition des actions). · ISTAR MEDICAL
- Filing representative: scope: Exécuter toutes les formalités nécessaires auprès de toute administration compétente (greffe, BCE, TVA), mettre à jour le registre des actions, et faire tout ce qui est nécessaire pour l'exécution des résolutions. · Van Bael & Bellis
- Capital increase: currency: EUR, condition: suspensive, linked_to: exercice des droits de souscription de classe D, max_amount: multiplication du nombre de droits de souscription de classe D exercés par le prix d'exercice, shares_issued: Actions Privilégiées de Classe D · ISTAR MEDICAL
Technical details
{
"facts": [
{
"type": "act_object",
"quote": "Objet de l\u0027acte : CAPITAL, ACTIONS, STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS)",
"value": "CAPITAL, ACTIONS, STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS)",
"object": null,
"subject": "e1"
},
{
"date": "2026-06-30",
"type": "publication",
"quote": "Bijlagen bij het Belgisch Staatsblad - 30/06/2026 - Annexes du Moniteur belge",
"value": "30/06/2026",
"object": null,
"subject": "e1"
},
{
"date": "2026-06-26",
"type": "filing",
"quote": "D\u00E9pos\u00E9 26-06-2026",
"value": "26-06-2026",
"object": null,
"subject": "e1"
},
{
"date": "2026-06-19",
"type": "notarial_deed",
"quote": "Ce jour, le dix-neuf juin deux mille vingt-six.",
"value": "19/06/2026",
"object": "e2",
"subject": "e1"
},
{
"date": "2026-06-19",
"type": "general_meeting",
"quote": "Ce jour, le dix-neuf juin deux mille vingt-six. (...) S\u2019EST REUNIE L\u2019assembl\u00E9e g\u00E9n\u00E9rale extraordinaire",
"value": "19/06/2026",
"object": null,
"subject": "e1"
},
{
"type": "capital_increase",
"quote": "L\u0027assembl\u00E9e d\u00E9cide d\u0027augmenter le capital de la Soci\u00E9t\u00E9 \u00E0 concurrence de 1.500.000,00 EUR, pour le porter de 82.777.306,56 EUR \u00E0 84.277.306,56 EUR. (...) \u00E9mission de 44.117 Actions Privil\u00E9gi\u00E9es de Classe D (...) souscrites imm\u00E9diatement en num\u00E9raire au prix (arrondi) de 34,00 EUR chacune",
"value": {
"after": "84.277.306,56 EUR",
"delta": "1.500.000,00 EUR",
"amount": 84277306.56,
"before": "82.777.306,56 EUR",
"paid_up": "100%",
"currency": "EUR",
"shares_issued": "44.117 Actions Privil\u00E9gi\u00E9es de Classe D",
"price_per_share": "34,00 EUR"
},
"amount": 1500000.0,
"object": null,
"subject": "e1",
"currency": "EUR",
"_value_raw": {
"after": "84.277.306,56 EUR",
"delta": "1.500.000,00 EUR",
"before": "82.777.306,56 EUR",
"paid_up": "100%",
"shares_issued": "44.117 Actions Privil\u00E9gi\u00E9es de Classe D",
"price_per_share": "34,00 EUR"
}
},
{
"type": "share_issue",
"quote": "SEPTIEME RESOLUTION : Emission de 88.234 droits de souscription de classe D.",
"value": {
"type": "droits de souscription de classe D",
"count": "88.234"
},
"object": null,
"subject": "e1"
},
{
"type": "capital",
"quote": "5.1. Le capital est fix\u00E9 \u00E0 quatre-vingt-quatre millions deux cent soixante-sept mille trois cent six euros cinquante-six cents (\u20AC 84.277.306,56). Le capital est repr\u00E9sent\u00E9 par deux millions deux cent soixante-huit mille neuf cent quarante-huit (2.268.948) actions...",
"value": {
"amount": 84277306.56,
"shares": "2.268.948",
"classes": [
{
"name": "Actions Ordinaires",
"count": "1.421.367"
},
{
"name": "Actions Privil\u00E9gi\u00E9es de Classe D",
"count": "847.581"
}
],
"currency": "EUR"
},
"amount": 84277306.56,
"object": null,
"subject": "e1",
"currency": "EUR",
"_value_raw": {
"amount": "84.277.306,56 EUR",
"shares": "2.268.948",
"classes": [
{
"name": "Actions Ordinaires",
"count": "1.421.367"
},
{
"name": "Actions Privil\u00E9gi\u00E9es de Classe D",
"count": "847.581"
}
]
}
},
{
"type": "statute_amendment",
"quote": "SIXIEME RESOLUTION : Modification de l\u2019article 5 des statuts. Afin de mettre les statuts en concordance avec les r\u00E9solutions prises, l\u0027assembl\u00E9e d\u00E9cide de remplacer l\u0027article 5 des statuts par le texte suivant...",
"value": "Remplacement de l\u0027article 5 des statuts pour mettre en concordance avec les r\u00E9solutions prises (capital et r\u00E9partition des actions).",
"object": null,
"subject": "e1"
},
{
"type": "filing_representative",
"quote": "QUATORZIEME RESOLUTION : Procuration pour les formalit\u00E9s. L\u2019assembl\u00E9e d\u00E9cide de conf\u00E9rer tous pouvoirs \u00E0 (i) chacun des administrateurs de la Soci\u00E9t\u00E9... ainsi qu\u2019\u00E0 (ii) Madame Caroline Daout... Madame Virginie Lescot... Madame Stefania Sacuiu... ou tout autre avocat du cabinet d\u2019avocats \u0022Van Bael \u0026 Bellis\u0022... afin (a) d\u2019ex\u00E9cuter toutes les formalit\u00E9s n\u00E9cessaires... (b) de mettre \u00E0 jour le registre des actions... (c) de faire en g\u00E9n\u00E9ral tout ce qui est n\u00E9cessaire...",
"value": {
"scope": "Ex\u00E9cuter toutes les formalit\u00E9s n\u00E9cessaires aupr\u00E8s de toute administration comp\u00E9tente (greffe, BCE, TVA), mettre \u00E0 jour le registre des actions, et faire tout ce qui est n\u00E9cessaire pour l\u0027ex\u00E9cution des r\u00E9solutions.",
"holders": [
"administrateurs de la Soci\u00E9t\u00E9",
"Caroline Daout",
"Virginie Lescot",
"Stefania Sacuiu",
"tout autre avocat du cabinet Van Bael \u0026 Bellis"
]
},
"object": "e1",
"subject": "e7"
},
{
"type": "capital_increase",
"quote": "DIXIEME RESOLUTION : Augmentation de capital de la Soci\u00E9t\u00E9 sous condition suspensive. L\u2019assembl\u00E9e d\u00E9cide - sous la condition suspensive et dans la mesure de l\u0027exercice de tout ou partie des droits de souscription de classe D - de proc\u00E9der \u00E0 une augmentation de capital en num\u00E9raire d\u0027un montant maximum \u00E9gal \u00E0 la multiplication du nombre de droits de souscription de classe D exerc\u00E9s par le prix d\u0027exercice de ces droits de souscription de classe D, et \u00E0 l\u0027\u00E9mission d\u0027un nombre d\u0027Actions Privil\u00E9gi\u00E9es de Classe D qui jouiront des m\u00EAmes droits et avantages que les actions existantes de la m\u00EAme classe respective, tel qu\u2019indiqu\u00E9 dans les modalit\u00E9s d\u0027\u00E9mission et conditions d\u0027exercice des droits de souscription.",
"value": {
"currency": "EUR",
"condition": "suspensive",
"linked_to": "exercice des droits de souscription de classe D",
"max_amount": "multiplication du nombre de droits de souscription de classe D exerc\u00E9s par le prix d\u0027exercice",
"shares_issued": "Actions Privil\u00E9gi\u00E9es de Classe D"
},
"object": null,
"subject": "e1",
"_value_raw": {
"condition": "suspensive",
"linked_to": "exercice des droits de souscription de classe D",
"max_amount": "multiplication du nombre de droits de souscription de classe D exerc\u00E9s par le prix d\u0027exercice",
"shares_issued": "Actions Privil\u00E9gi\u00E9es de Classe D"
}
}
],
"act_meta": {
"outcome": "corrected",
"model_id": 50,
"verified": true,
"extractor": "verified-v1",
"ocr_chars": 9389,
"truncated": false,
"completeness_doubt": [
"Cancellation of pre-emption rights (Suppression du droit de pr\u00E9f\u00E9rence) for the immediate capital increase and for the subscription rights"
]
},
"entities": [
{
"id": "e1",
"kbo": "0828.058.712",
"kind": "company",
"name": "ISTAR MEDICAL",
"attrs": {
"seat": "Avenue Sabin 6, 1300 Wavre",
"legal_form": "Soci\u00E9t\u00E9 anonyme"
}
},
{
"id": "e2",
"kbo": null,
"kind": "person",
"name": "Peter VAN MELKEBEKE",
"attrs": {
"role": "Notaire",
"address": "1000 Bruxelles, Avenue Lloyd George 11"
}
},
{
"id": "e3",
"kbo": null,
"kind": "org",
"name": "BERQUIN NOTAIRES",
"attrs": {
"address": "1000 Bruxelles, Avenue Lloyd George 11"
}
},
{
"id": "e4",
"kbo": null,
"kind": "person",
"name": "Caroline Daout",
"attrs": {
"role": "avocate"
}
},
{
"id": "e5",
"kbo": null,
"kind": "person",
"name": "Virginie Lescot",
"attrs": {
"role": "avocate"
}
},
{
"id": "e6",
"kbo": null,
"kind": "person",
"name": "Stefania Sacuiu",
"attrs": {
"role": "avocate"
}
},
{
"id": "e7",
"kbo": null,
"kind": "org",
"name": "Van Bael \u0026 Bellis",
"attrs": {
"address": "chauss\u00E9e de La Hulpe 166, 1170 Bruxelles"
}
}
]
}20-05-2026 Notarial deed · General meeting · Capital increase · Auditor report
- Filing: 2026-05-18 · ISTAR MEDICAL
- Notarial deed: 2026-05-06 · ISTAR MEDICAL
- General meeting: 2026-05-06 · ISTAR MEDICAL
- Capital increase: share_type: Actions Privilégiées de Classe D, shares_issued: 29411, payment_method: numéraire · ISTAR MEDICAL
- Capital increase: share_type: Actions Privilégiées de Classe D, shares_issued: 21094, payment_method: apport en nature (créance) · ISTAR MEDICAL
- Capital increase: share_type: Actions de Classe D, bank_account: compte spécial (…) BNP Paribas Fortis, shares_issued: 202020, payment_method: numéraire · ISTAR MEDICAL
- Capital increase: share_type: Actions Ordinaires, shares_issued: 974451, payment_method: apport en nature (créance) · ISTAR MEDICAL
- Auditor report: 2026-04-30 · ISTAR MEDICAL
- Statute amendment: nouveau texte des statuts · ISTAR MEDICAL
- Officer resignation: role: administrateur, effective_date: 2025-12-31 · GUYER David
- Power of attorney: formalités · ISTAR MEDICAL
- Power of attorney: formalités · ISTAR MEDICAL
- Power of attorney: formalités · ISTAR MEDICAL
- Power of attorney: formalités · ISTAR MEDICAL
- Governance rule: conseil d'administration composé de sept (7) membres au plus · ISTAR MEDICAL
- Mandate term: quatre (4) ans au plus · ISTAR MEDICAL
- Representation rule: deux administrateurs agissants conjointement · ISTAR MEDICAL
- Annual meeting schedule: premier vendredi du mois de juin à quinze heures · ISTAR MEDICAL
- First fiscal year: 01-01 to 31-12 · ISTAR MEDICAL
- Share distribution: total_shares: 2224831 · ISTAR MEDICAL
- Publication: 2026-05-20
- Act object: STATUTS (TRADUCTION, COORDINATION, AUTRES
Technical details
{
"facts": [
{
"type": "filing",
"quote": "D\u00E9pos\u00E9 18-05-2026",
"value": "2026-05-18",
"object": null,
"subject": "e1"
},
{
"type": "notarial_deed",
"quote": "Ce jour, le six mai deux mille vingt-six.",
"value": "2026-05-06",
"object": "e2",
"subject": "e1"
},
{
"type": "general_meeting",
"quote": "Ce jour, le six mai deux mille vingt-six. (\u2026) S\u2019EST REUNIE L\u2019assembl\u00E9e g\u00E9n\u00E9rale extraordinaire de la soci\u00E9t\u00E9 anonyme \u0022ISTAR MEDICAL\u0022",
"value": "2026-05-06",
"object": null,
"subject": "e1"
},
{
"type": "capital_increase",
"quote": "L\u0027assembl\u00E9e d\u00E9cide d\u0027augmenter le capital de la Soci\u00E9t\u00E9 \u00E0 concurrence de 1.000.000,00 EUR, pour le porter de 48.141.860,16 EUR \u00E0 un montant de 49.141.860,16 EUR. (\u2026) \u00E9mission de 29.411 Actions Privil\u00E9gi\u00E9es de Classe D (\u2026) souscrites imm\u00E9diatement en num\u00E9raire au prix (arrondi) de 34,00 EUR chacune",
"value": {
"delta": {
"amount": 1000000.0,
"currency": "EUR"
},
"share_type": "Actions Privil\u00E9gi\u00E9es de Classe D",
"amount_after": {
"amount": 49141860.16,
"currency": "EUR"
},
"amount_before": {
"amount": 48141860.16,
"currency": "EUR"
},
"shares_issued": 29411,
"payment_method": "num\u00E9raire",
"subscription_price": {
"amount": 34.0,
"currency": "EUR"
}
},
"object": null,
"subject": "e1"
},
{
"type": "capital_increase",
"quote": "L\u0027assembl\u00E9e d\u00E9cide d\u0027augmenter le capital de la Soci\u00E9t\u00E9 \u00E0 concurrence de 502.082,20 EUR, pour le porter de 49.141.860,16 EUR \u00E0 49.643.942,36 EUR, par l\u2019\u00E9mission de 21.094 Actions Privil\u00E9gi\u00E9es de Classe D \u00E9mises \u00E0 un prix de souscription \u00E9gal \u00E0 70% du prix de souscription des Actions Privil\u00E9gi\u00E9es de Classe D (\u2026) r\u00E9alis\u00E9e par l\u2019apport par les Apporteurs Privil\u00E9gi\u00E9s (\u2026) d\u2019une cr\u00E9ance certaine, liquide et exigible",
"value": {
"delta": {
"amount": 502082.2,
"currency": "EUR"
},
"share_type": "Actions Privil\u00E9gi\u00E9es de Classe D",
"amount_after": {
"amount": 49643942.36,
"currency": "EUR"
},
"amount_before": {
"amount": 49141860.16,
"currency": "EUR"
},
"shares_issued": 21094,
"payment_method": "apport en nature (cr\u00E9ance)",
"subscription_price": {
"amount": 23.8,
"currency": "EUR"
}
},
"object": null,
"subject": "e1"
},
{
"type": "capital_increase",
"quote": "Le capital est d\u00E8s lors augment\u00E9 \u00E0 concurrence de 2.020,20 EUR et port\u00E9 de 49.643.942,16 EUR \u00E0 49.645.962,36 EUR. (\u2026) souscrites en esp\u00E8ces \u00E0 l\u0027instant au prix total de 0,01 EUR (\u2026) sur un compte sp\u00E9cial (\u2026) tel qu\u2019il r\u00E9sulte d\u0027une attestation bancaire d\u00E9livr\u00E9e par la banque BNP Paribas Fortis en date du 6 mai 2026",
"value": {
"delta": {
"amount": 2020.2,
"currency": "EUR"
},
"share_type": "Actions de Classe D",
"amount_after": {
"amount": 49645962.36,
"currency": "EUR"
},
"bank_account": "compte sp\u00E9cial (\u2026) BNP Paribas Fortis",
"amount_before": {
"amount": 49643942.16,
"currency": "EUR"
},
"shares_issued": 202020,
"payment_method": "num\u00E9raire",
"subscription_price": {
"amount": 0.01,
"currency": "EUR"
}
},
"object": null,
"subject": "e1"
},
{
"type": "capital_increase",
"quote": "L\u0027assembl\u00E9e d\u00E9cide d\u0027augmenter le capital de la Soci\u00E9t\u00E9 \u00E0 concurrence de 33.131.344,00 EUR, pour le porter de 49.645.962,56 EUR \u00E0 82.777.306,56 EUR, par l\u0027\u00E9mission de 974.451 Actions Ordinaires (\u2026) r\u00E9alis\u00E9e par l\u2019apport par les Apporteurs Ordinaires (\u2026) d\u2019une cr\u00E9ance certaine, liquide et exigible",
"value": {
"delta": {
"amount": 33131344.0,
"currency": "EUR"
},
"share_type": "Actions Ordinaires",
"amount_after": {
"amount": 82777306.56,
"currency": "EUR"
},
"amount_before": {
"amount": 49645962.56,
"currency": "EUR"
},
"shares_issued": 974451,
"payment_method": "apport en nature (cr\u00E9ance)",
"subscription_price": {
"amount": 34.0,
"currency": "EUR"
}
},
"object": null,
"subject": "e1"
},
{
"type": "auditor_report",
"quote": "Le rapport du commissaire en date du 30 avril 2026, \u00E9tabli par la soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e \u0022PwC R\u00E9viseurs d\u2019Entreprises\u0022 (\u2026) repr\u00E9sent\u00E9e par Patrick Mortroux, r\u00E9viseur d\u2019entreprises",
"value": "2026-04-30",
"object": "e3",
"subject": "e1"
},
{
"type": "statute_amendment",
"quote": "L\u2019assembl\u00E9e d\u00E9cide d\u2019adopter un nouveau texte des statuts afin de les mettre en conformit\u00E9 avec les r\u00E9solutions prises ci-dessus et la convention d\u2019actionnaires du 30 avril 2026.",
"value": "nouveau texte des statuts",
"object": null,
"subject": "e1"
},
{
"type": "officer_resignation",
"quote": "L\u2019assembl\u00E9e prend connaissance et accepte la d\u00E9mission de Monsieur GUYER David (\u2026) en tant qu\u2019administrateur de la Soci\u00E9t\u00E9, avec effet au 31 d\u00E9cembre 2025.",
"value": {
"role": "administrateur",
"effective_date": "2025-12-31"
},
"object": "e1",
"subject": "e5"
},
{
"type": "power_of_attorney",
"quote": "L\u2019assembl\u00E9e d\u00E9cide de conf\u00E9rer tous pouvoirs \u00E0 (\u2026) Madame Caroline Daout, avocate (\u2026) afin (a) d\u2019ex\u00E9cuter toutes les formalit\u00E9s n\u00E9cessaires aupr\u00E8s de toute administration comp\u00E9tente",
"value": "formalit\u00E9s",
"object": "e6",
"subject": "e1"
},
{
"type": "power_of_attorney",
"quote": "L\u2019assembl\u00E9e d\u00E9cide de conf\u00E9rer tous pouvoirs \u00E0 (\u2026) Madame Virginie Lescot, avocate (\u2026) afin (a) d\u2019ex\u00E9cuter toutes les formalit\u00E9s n\u00E9cessaires aupr\u00E8s de toute administration comp\u00E9tente",
"value": "formalit\u00E9s",
"object": "e7",
"subject": "e1"
},
{
"type": "power_of_attorney",
"quote": "L\u2019assembl\u00E9e d\u00E9cide de conf\u00E9rer tous pouvoirs \u00E0 (\u2026) Madame Stefania Sacuiu, avocate (\u2026) afin (a) d\u2019ex\u00E9cuter toutes les formalit\u00E9s n\u00E9cessaires aupr\u00E8s de toute administration comp\u00E9tente",
"value": "formalit\u00E9s",
"object": "e8",
"subject": "e1"
},
{
"type": "power_of_attorney",
"quote": "L\u2019assembl\u00E9e d\u00E9cide de conf\u00E9rer tous pouvoirs \u00E0 (\u2026) tout autre avocat du cabinet d\u2019avocats \u0022Van Bael \u0026 Bellis\u0022 (\u2026) afin (a) d\u2019ex\u00E9cuter toutes les formalit\u00E9s n\u00E9cessaires aupr\u00E8s de toute administration comp\u00E9tente",
"value": "formalit\u00E9s",
"object": "e9",
"subject": "e1"
},
{
"type": "governance_rule",
"quote": "La soci\u00E9t\u00E9 est administr\u00E9e par un conseil compos\u00E9 comme suit de sept (7) membres au plus",
"value": "conseil d\u0027administration compos\u00E9 de sept (7) membres au plus",
"object": null,
"subject": "e1"
},
{
"type": "mandate_term",
"quote": "nomm\u00E9s pour quatre (4) ans au plus par l\u0027assembl\u00E9e g\u00E9n\u00E9rale des actionnaires",
"value": "quatre (4) ans au plus",
"object": null,
"subject": "e1"
},
{
"type": "representation_rule",
"quote": "La soci\u00E9t\u00E9 est valablement repr\u00E9sent\u00E9e vis-\u00E0-vis de tiers (\u2026) par deux administrateurs agissants conjointement.",
"value": "deux administrateurs agissants conjointement",
"object": null,
"subject": "e1"
},
{
"type": "annual_meeting_schedule",
"quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale ordinaire des actionnaires se r\u00E9unit le premier vendredi du mois de juin \u00E0 quinze heures",
"value": "premier vendredi du mois de juin \u00E0 quinze heures",
"object": null,
"subject": "e1"
},
{
"type": "first_fiscal_year",
"quote": "L\u0027exercice social commence le premier janvier pour se terminer le trente et un d\u00E9cembre de chaque ann\u00E9e.",
"value": "01-01 to 31-12",
"object": null,
"subject": "e1"
},
{
"type": "share_distribution",
"quote": "Le capital est repr\u00E9sent\u00E9 par deux millions deux cent vingt-quatre mille huit cent trente-et-une (2.224.831) actions (\u2026) r\u00E9parties comme suit en deux classes d\u2019actions, \u00E9tant : (i) les \u00AB Actions Ordinaires \u00BB, au nombre de un million quatre cent vingt-et-un mille trois cent soixante-sept (1.421.367) (\u2026) et (ii) les \u00AB Actions Privil\u00E9gi\u00E9es de Classe D \u00BB, au nombre de huit cent trois mille quatre cent soixante-quatre (803.464)",
"value": {
"classes": [
{
"name": "Actions Ordinaires",
"count": 1421367
},
{
"name": "Actions Privil\u00E9gi\u00E9es de Classe D",
"count": 803464
}
],
"total_shares": 2224831
},
"object": null,
"subject": "e1"
},
{
"type": "publication",
"quote": "Belgisch Staatsblad - 20/05/2026",
"value": "2026-05-20",
"object": null,
"subject": null
},
{
"type": "act_object",
"quote": "Objet de l\u0027acte : STATUTS (TRADUCTION, COORDINATION, AUTRES",
"value": "STATUTS (TRADUCTION, COORDINATION, AUTRES",
"object": null,
"subject": null
}
],
"act_meta": {
"model_id": 40,
"extractor": "open-capture-27b-v3",
"ocr_chars": 44443,
"truncated": false,
"needs_verify": true
},
"entities": [
{
"id": "e1",
"kbo": "0828.058.712",
"kind": "company",
"name": "ISTAR MEDICAL",
"attrs": {
"seat": "Avenue Sabin 6, 1300 Wavre",
"legal_form": "Soci\u00E9t\u00E9 anonyme"
}
},
{
"id": "e2",
"kbo": null,
"kind": "person",
"name": "Peter VAN MELKEBEKE",
"attrs": {
"firm": "BERQUIN NOTAIRES",
"role": "notaire",
"firm_seat": "1000 Bruxelles, Avenue Lloyd George 11"
}
},
{
"id": "e3",
"kbo": null,
"kind": "org",
"name": "PwC R\u00E9viseurs d\u2019Entreprises",
"attrs": {
"seat": "4000 Li\u00E8ge, Vis\u00E9-Voie 81 bo\u00EEte ABC",
"legal_form": "soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e"
}
},
{
"id": "e4",
"kbo": null,
"kind": "person",
"name": "Patrick Mortroux",
"attrs": {
"firm": "Patrick Mortroux SRL",
"role": "r\u00E9viseur d\u2019entreprises"
}
},
{
"id": "e5",
"kbo": null,
"kind": "person",
"name": "GUYER David",
"attrs": {
"birth_date": "1960-01-03",
"birth_place": "New-York (Etats-Unis d\u2019Am\u00E9rique)"
}
},
{
"id": "e6",
"kbo": null,
"kind": "person",
"name": "Caroline Daout",
"attrs": {
"firm": "Van Bael \u0026 Bellis",
"role": "avocate"
}
},
{
"id": "e7",
"kbo": null,
"kind": "person",
"name": "Virginie Lescot",
"attrs": {
"firm": "Van Bael \u0026 Bellis",
"role": "avocate"
}
},
{
"id": "e8",
"kbo": null,
"kind": "person",
"name": "Stefania Sacuiu",
"attrs": {
"firm": "Van Bael \u0026 Bellis",
"role": "avocate"
}
},
{
"id": "e9",
"kbo": null,
"kind": "org",
"name": "Van Bael \u0026 Bellis",
"attrs": {
"seat": "chauss\u00E9e de La Hulpe 166, 1170 Bruxelles",
"type": "cabinet d\u2019avocats"
}
},
{
"id": "e10",
"kbo": null,
"kind": "org",
"name": "BNP Paribas Fortis",
"attrs": {
"type": "banque"
}
}
]
}09-01-2026 Capital increase of €3,057,487 to €48,141,860.16
- €45.084.373,16 → €48.141.860,16
Technical details
{
"events": [
{
"kind": "capital_increase",
"amount": 3057487.0,
"currency": "EUR",
"after_eur": 48141860.16,
"delta_eur": 3057487.0,
"before_eur": 45084373.16,
"amount_type": "kapitaal_effectief",
"effective_date": "2025-12-24",
"evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide d\u0027augmenter le capital de la Soci\u00E9t\u00E9 \u00E0 concurrence de 3.057.487,00 EUR, pour le porter de 45.084.373,16 EUR \u00E0 48.141.860,16 EUR. L\u0027assembl\u00E9e d\u00E9cide que l\u0027augmentation de capital sera r\u00E9alis\u00E9e par apport en num\u00E9raire",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0828.058.712",
"name_full": "ISTAR MEDICAL",
"legal_form": "SA"
}
}28-11-2025 Capital increase of €1,033,105 to €45,084,373.16
- €44.051.268,16 → €45.084.373,16
- 2 kapitaalbewegingen in deze akte
Technical details
{
"events": [
{
"kind": "capital_increase",
"amount": 57060.0,
"currency": "EUR",
"after_eur": 44051268.16,
"delta_eur": 57060.0,
"before_eur": 43994208.16,
"amount_type": "kapitaal_effectief",
"effective_date": "2025-11-20",
"evidence_quote": "Le capital est d\u00E8s lors augment\u00E9 \u00E0 concurrence de 57.060,00 EUR et port\u00E9 de 43.994.208,16 EUR \u00E0 44.051.268,16 EUR. Ladite augmentation du capital est r\u00E9alis\u00E9e par l\u2019\u00E9mission de 563 nouvelles Actions Ordinaires de la Soci\u00E9t\u00E9... Lesdites nouvelles actions ont \u00E9t\u00E9 imm\u00E9diatement souscrites en esp\u00E8ces au prix total de 57.060,00 EUR",
"contribution_type": "cash"
},
{
"kind": "capital_increase",
"amount": 1033105.0,
"currency": "EUR",
"after_eur": 45084373.16,
"delta_eur": 1033105.0,
"before_eur": 44051268.16,
"amount_type": "kapitaal_effectief",
"effective_date": "2025-11-20",
"evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide d\u0027augmenter le capital de la Soci\u00E9t\u00E9 \u00E0 concurrence de 1.033.105,00 EUR, pour le porter de 44.051.268,16 EUR \u00E0 45.084.373,16 EUR. L\u0027assembl\u00E9e d\u00E9cide que l\u0027augmentation de capital sera r\u00E9alis\u00E9e par apport en num\u00E9raire... L\u0027assembl\u00E9e d\u00E9cide que les nouvelles Actions Privil\u00E9gi\u00E9es de Classe D seront souscrites imm\u00E9diatement en num\u00E9raire... et que les actions nouvelles seront lib\u00E9r\u00E9es \u00E0 concurrence de 100%, \u00E0 savoir 1.033.105,00 EUR.",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0828.058.712",
"name_full": "ISTAR MEDICAL",
"legal_form": "SA"
}
}17-10-2025 VANBRABANT Michel appointed as director
- VANBRABANT Michel, Bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "VANBRABANT Michel",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0781705776",
"name": "MV Lifesciences",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2024-01-01",
"evidence_quote": "A toutes fins utiles et pour autant que de besoin, l\u2019assembl\u00E9e d\u00E9cide de nommer et de ratifier la nomination de la soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e MV Lifesciences, dont le si\u00E8ge est situ\u00E9 rue de Genval 22, 1331 Rosi\u00E8res (Belgique) et inscrite aupr\u00E8s du registre des personnes morales du Brabant wall"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0828.058.712",
"name_full": "ISTAR MEDICAL",
"legal_form": "SA"
}
}26-09-2024 1 director appointed, 3 reappointed
- Rick (Richard) Beckman, Bestuurder
- Michel Vanbrabant, Gedelegeerd bestuurder
- Filip Pintelon, Bestuurder
- Patrick Mort, Commissaris
Technical details
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Rick (Richard) Beckman",
"address": null,
"birth_date": null
},
"effective_date": "2024-04-16",
"evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide de nommer Rick (Richard) Beckman, [...], en qualit\u00E9 d\u0027administrateur de la Soci\u00E9t\u00E9, avec effet au 16 avril 2024 et, pour autant que de besoin, l\u0027assembl\u00E9e g\u00E9n\u00E9rale confirme la cooptation de Rick Beckman en qualit\u00E9 d\u0027administrateur par le conseil d\u0027administration en date d"
},
{
"kind": "director_renew",
"role": "gedelegeerd_bestuurder",
"person": {
"rrn": null,
"name": "Michel Vanbrabant",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "MV Lifesciences SRL",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "(1) MV Lifesciences SRL, repr\u00E9sent\u00E9e par son repr\u00E9sentant permanent M. Michel Vanbrabant, qui poursuit son mandat d\u0027administrateur d\u00E9l\u00E9gu\u00E9;"
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Filip Pintelon",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "Capricorn Partners NV",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "(4) Capricorn Partners NV, repr\u00E9sent\u00E9e par son repr\u00E9sentant permanent M. Filip Pintelon;"
},
{
"kind": "commissaris_renew",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Patrick Mort",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "PWC R\u00E9viseurs d\u0027Entreprises SRL",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2024-07-26",
"evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale prend note du fait que M\u00E9lanie Adorante sera remplac\u00E9e en qualit\u00E9 de repr\u00E9sentante permanente du commissaire de la Soci\u00E9t\u00E9, PWC R\u00E9viseurs d\u0027Entreprises SRL, par M. Patrick Mort, [...], ave\u0441 effet en date du 26 Juillet 2024."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0828.058.712",
"name_full": "ISTAR MEDICAL",
"legal_form": "SA"
}
}16-04-2024 Michel Lussier resigns as director
- Michel Lussier, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Michel Lussier",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0681994330",
"name": "Mel Management",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2024-01-25",
"evidence_quote": "Les actionnaires prennent connaissance de et, pour autant que de besoin, acceptent la d\u00E9mission de Mel Management, une soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e de droit belge, ayant son si\u00E8ge Rue de Combreuil 3, 7190 Ecaussinnes (Belgique), et enregistr\u00E9e au Registre des personnes morales du Hainaut, divisi"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0828.058.712",
"name_full": "ISTAR MEDICAL",
"legal_form": "SA"
}
}31-07-2023 8 reappointed
- Michel Lussier, Bestuurder
- Filip Pintelon, Bestuurder
- M. Marc Nolet de Brauwere van Steeland, Bestuurder
- M. Marty Wax, Bestuurder
- M. David Guyer, Bestuurder
- M. Bram Vanparys, Bestuurder
- M. Lionel Carnot, Bestuurder
- Mélanie Adorante, Commissaris
Technical details
{
"events": [
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Michel Lussier",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "MEL Management SRL",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2023-07-31",
"evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide de r\u00E9\u00E9lire pour une p\u00E9riode de quatre ans, \u00E0 compter du 31 juillet 2023, les personnes suivantes en qualit\u00E9 d\u0027administrateurs de la Soci\u00E9t\u00E9: ... (4) Mel Management SRL, repr\u00E9sent\u00E9e par son repr\u00E9sentant permanent M. Michel Lussier;",
"discharge_granted": true
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Filip Pintelon",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "Capricorn Partners NV",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2023-07-31",
"evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide de r\u00E9\u00E9lire pour une p\u00E9riode de quatre ans, \u00E0 compter du 31 juillet 2023, les personnes suivantes en qualit\u00E9 d\u0027administrateurs de la Soci\u00E9t\u00E9: ... (2) Capricorn Partners NV, repr\u00E9sent\u00E9e par son repr\u00E9sentant permanent M. Filip Pintelon;",
"discharge_granted": true
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "M. Marc Nolet de Brauwere van Steeland",
"address": null,
"birth_date": null
},
"effective_date": "2023-07-31",
"evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide de r\u00E9\u00E9lire pour une p\u00E9riode de quatre ans, \u00E0 compter du 31 juillet 2023, les personnes suivantes en qualit\u00E9 d\u0027administrateurs de la Soci\u00E9t\u00E9: (1) M. Marc Nolet de Brauwere van Steeland;",
"discharge_granted": true
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "M. Marty Wax",
"address": null,
"birth_date": null
},
"effective_date": "2023-07-31",
"evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide de r\u00E9\u00E9lire pour une p\u00E9riode de quatre ans, \u00E0 compter du 31 juillet 2023, les personnes suivantes en qualit\u00E9 d\u0027administrateurs de la Soci\u00E9t\u00E9: ... (3) M. Marty Wax;",
"discharge_granted": true
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "M. David Guyer",
"address": null,
"birth_date": null
},
"effective_date": "2023-07-31",
"evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide de r\u00E9\u00E9lire pour une p\u00E9riode de quatre ans, \u00E0 compter du 31 juillet 2023, les personnes suivantes en qualit\u00E9 d\u0027administrateurs de la Soci\u00E9t\u00E9: ... (6) M. David Guyer;",
"discharge_granted": true
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "M. Bram Vanparys",
"address": null,
"birth_date": null
},
"effective_date": "2023-07-31",
"evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide de r\u00E9\u00E9lire pour une p\u00E9riode de quatre ans, \u00E0 compter du 31 juillet 2023, les personnes suivantes en qualit\u00E9 d\u0027administrateurs de la Soci\u00E9t\u00E9: ... (6) M. Bram Vanparys;",
"discharge_granted": true
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "M. Lionel Carnot",
"address": null,
"birth_date": null
},
"effective_date": "2023-07-31",
"evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide de r\u00E9\u00E9lire pour une p\u00E9riode de quatre ans, \u00E0 compter du 31 juillet 2023, les personnes suivantes en qualit\u00E9 d\u0027administrateurs de la Soci\u00E9t\u00E9: ... (7) M. Lionel Carnot.",
"discharge_granted": true
},
{
"kind": "commissaris_renew",
"role": "commissaris",
"person": {
"rrn": null,
"name": "M\u00E9lanie Adorante",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0429501944",
"name": "PWC R\u00E9viseurs d\u0027Entreprises",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide de renouveler le mandat de PWC R\u00E9viseurs d\u0027Entreprises, une soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 de droit belge, ayant son si\u00E8ge Culliglaan 5 \u00E0 1831 Machelen (Belgique), enregistr\u00E9e au Registre des Personnes Morales de Bruxelles (section n\u00E9erlandophone) sous le num\u00E9ro 0429.501.944, e",
"discharge_granted": true
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0828.058.712",
"name_full": "ISTAR MEDICAL",
"legal_form": "SA"
}
}26-05-2023 Change in the board of directors
Technical details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0828.058.712",
"name_full": "ISTAR MEDICAL",
"legal_form": "SA"
}
}02-03-2023 HOLTHOF Bruno Luc Myriam Jozef appointed as director
- HOLTHOF Bruno Luc Myriam Jozef, Bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "HOLTHOF Bruno Luc Myriam Jozef",
"address": null,
"birth_date": null
},
"effective_date": "2023-01-01",
"evidence_quote": "L\u2019assembl\u00E9e d\u00E9cide de nommer en tant que nouvel administrateur, Monsieur HOLTHOF Bruno Luc Myriam Jozef, n\u00E9 \u00E0 Wilrijk le 10 juillet 1961, (\u2026), avec effet au 1er janvier 2023."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0828.058.712",
"name_full": "ISTAR MEDICAL",
"legal_form": "SA"
}
}08-08-2022 Capital increase of €41,031,652.98 to €41,962,852.16
- €931.199,18 → €41.962.852,16
Technical details
{
"events": [
{
"kind": "capital_increase",
"amount": 41031652.98,
"currency": "EUR",
"after_eur": 41962852.16,
"delta_eur": 41031652.98,
"before_eur": 931199.18,
"amount_type": "kapitaal_effectief",
"effective_date": "2022-07-25",
"evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide d\u0027augmenter le capital de la Soci\u00E9t\u00E9 en num\u00E9raire d\u0027un montant \u00E9gal \u00E0 la contre-valeur en euros de maximum 42.000.000,00 USD, calcul\u00E9 sur base du cours du change du jour de l\u0027assembl\u00E9e g\u00E9n\u00E9rale extraordinaire, au cours de laquelle l\u0027augmentation de capital sera pr\u00E9sent\u00E9e, tel que d\u00E9termin\u00E9 et publi\u00E9 sur le site Internet de la Banque centrale europ\u00E9enne (1 EUR = 1.0236 USD), soit un montant de 41.031.652,98 EUR, pour le porter de 931.199,18 EUR \u00E0 41.962.852,16 EUR",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0828.058.712",
"name_full": "ISTAR MEDICAL",
"legal_form": "SA"
}
}23-02-2022 Capital increase of €156,028.58 to €929,467.96
- €773.439,38 → €929.467,96
- 3 kapitaalbewegingen in deze akte
Technical details
{
"events": [
{
"kind": "capital_increase",
"amount": 76868.85,
"currency": "EUR",
"after_eur": 773439.38,
"delta_eur": 76868.85,
"before_eur": 696570.53,
"amount_type": "kapitaal_effectief",
"effective_date": "2022-02-16",
"evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide d\u0027augmenter le capital de la Soci\u00E9t\u00E9 \u00E0 concurrence de 76.868,85 EUR, pour le porter de 696.570,53 EUR \u00E0 773.439,38 EUR, par l\u0027\u00E9mission de 24.998 actions privil\u00E9gi\u00E9es de classe C ... L\u0027assembl\u00E9e d\u00E9cide que l\u0027augmentation du capital sera r\u00E9alis\u00E9e par l\u0027apport d\u0027une cr\u00E9ance certaine, liquide et exigible",
"contribution_type": "in_kind"
},
{
"kind": "capital_increase",
"amount": 156028.58,
"currency": "EUR",
"after_eur": 929467.96,
"delta_eur": 156028.58,
"before_eur": 773439.38,
"amount_type": "kapitaal_effectief",
"effective_date": "2022-02-16",
"evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide d\u0027augmenter le capital de la Soci\u00E9t\u00E9 \u00E0 concurrence de 156.028,58 EUR, pour le porter de 773.439,38 EUR \u00E0 929.467,96 EUR. L\u0027assembl\u00E9e d\u00E9cide que l\u0027augmentation de capital sera r\u00E9alis\u00E9e par apport en num\u00E9raire ... Les actions nouvelles seront souscrites imm\u00E9diatement en num\u00E9raire au prix de 200,00 EUR chacune ... (i) 3,075 EUR par action sera comptabilis\u00E9 sur un compte \u0022 Capital \u0022, soit au total 156.028,58 EUR",
"contribution_type": "cash"
},
{
"kind": "capital_increase",
"amount": 1731.22,
"currency": "EUR",
"after_eur": 931199.18,
"delta_eur": 1731.22,
"before_eur": 929467.96,
"amount_type": "kapitaal_effectief",
"effective_date": "2022-02-16",
"evidence_quote": "Le capital est d\u00E8s lors augment\u00E9 \u00E0 concurrence de 1.731,22 EUR et port\u00E9 de 929.467,96 EUR \u00E0 931.199,18 EUR. Ladite augmentation du capital est r\u00E9alis\u00E9e par l\u0027\u00E9mission de 563 nouvelles actions ordinaires de la Soci\u00E9t\u00E9 ... Lesdites nouvelles actions ont \u00E9t\u00E9 imm\u00E9diatement souscrites en esp\u00E8ces ... Par action : (i) 3,075 EUR, \u00E9tant le pair comptable par action, sera comptabilis\u00E9 sur le compte \u0022 Capital \u0022, soit au total 1.731,22 EUR",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0828.058.712",
"name_full": "ISTAR MEDICAL",
"legal_form": "SA"
}
}18-11-2021 Articles of association amended
Technical details
{
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"statute_change": {
"name_change": false,
"seat_change": false,
"object_change": false,
"effective_date": "2021-10-29",
"legal_form_change": false
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0828.058.712",
"name_full": "ISTAR MEDICAL",
"legal_form": "SA"
},
"signature_regime": "joint_two",
"special_mandates": [],
"governance_change": {
"admin_delegated_added": []
}
}30-08-2021 Articles of association amended
Technical details
{
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"statute_change": {
"name_change": false,
"seat_change": false,
"object_change": false,
"effective_date": "2021-08-10",
"legal_form_change": false
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0828.058.712",
"name_full": "ISTAR MEDICAL",
"legal_form": "SA"
},
"signature_regime": null,
"special_mandates": [],
"governance_change": {
"admin_delegated_added": []
}
}07-12-2020 Mélanie Adorante reappointed as statutory auditor
- Mélanie Adorante, Commissaris
Technical details
{
"events": [
{
"kind": "commissaris_renew",
"role": "commissaris",
"person": {
"rrn": null,
"name": "M\u00E9lanie Adorante",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0429501944",
"name": "PWC R\u00E9viseurs d\u0027entreprises SRL",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "L\u0027Assembl\u00E9e G\u00E9n\u00E9rale a proc\u00E9d\u00E9 \u00E0 la r\u00E9\u00E9lection de PWC R\u00E9viseurs d\u0027entreprises SRL (Entreprise # 0429.501.944), repr\u00E9sent\u00E9 par M\u00E9lanie Adorante (membre # A02225), \u00E0 la fonction de commissaire pour un nouveau mandat de trois ans."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0828.058.712",
"name_full": "ISTAR MEDICAL",
"legal_form": "SA"
}
}24-01-2020 1 director appointed, 1 reappointed
- Michel Lussier, Vaste vertegenwoordiger
- Michel Vanbrabant, Vaste vertegenwoordiger
Technical details
{
"events": [
{
"kind": "director_in",
"role": "vaste_vertegenwoordiger",
"person": {
"rrn": null,
"name": "Michel Lussier",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "Mel Management SPRL",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2019-07-31",
"evidence_quote": "l\u0027administrateur d\u00E9l\u00E9gu\u00E9 et les Administrateurs Investisseurs proposent la nomination au titre de pr\u00E9sident du conseil d\u0027administration pour un mandat de 4 ans, avec effet r\u00E9troactif au 31 juillet 2019: - Mel Management SPRL, repr\u00E9sent\u00E9e par son repr\u00E9sentant permanent Monsieur Michel Lussier;"
},
{
"kind": "director_renew",
"role": "vaste_vertegenwoordiger",
"person": {
"rrn": null,
"name": "Michel Vanbrabant",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0832578021",
"name": "New Breath SPRL",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2019-07-31",
"evidence_quote": "En vertu de l\u0027article 14. $3 des statuts, le conseil d\u0027administration d\u00E9cide de r\u00E9\u00E9lire New Breath SPRL (RPM 832.578.021), ayant son si\u00E8ge social situ\u00E9 Rue de Genval 22 \u00E0 1331 Rixensart, et repr\u00E9sent\u00E9e par son repr\u00E9sentant permanent Monsieur Michel Vanbrabant, comme administrateur-d\u00E9l\u00E9gu\u00E9 charg\u00E9 de "
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0828.058.712",
"name_full": "ISTAR MEDICAL",
"legal_form": "SA"
}
}10-12-2019 Transaction in capital or shares
Technical details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0828.058.712",
"name_full": "ISTAR MEDICAL",
"legal_form": "SA"
}
}02-09-2019 3 directors appointed, 6 reappointed
- Bram Vanparys, Bestuurder
- Anne Portwich, Bestuurder
- Lionel Carnot, Bestuurder
- Michel Lussier, Bestuurder
- Michel Vanbrabant, Bestuurder
- Ekaterina Smirnyagina, Bestuurder
- Marc Nolet de Brauwere van Steeland, Bestuurder
- Marty Wax, Bestuurder
Technical details
{
"events": [
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Michel Lussier",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "Mel Management SPRL",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2019-09-02",
"evidence_quote": "de r\u00E9\u00E9lire les personnes suivantes en qualit\u00E9 d\u0027administrateurs de la Soci\u00E9t\u00E9, pour une dur\u00E9e de quatre (4) ans, avec effet imm\u00E9diat: oMel Management SPRL, repr\u00E9sent\u00E9e par son repr\u00E9sentant permanent Monsieur Michel Lussier;"
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Michel Vanbrabant",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "New Breath SPRL",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2019-09-02",
"evidence_quote": "de r\u00E9\u00E9lire les personnes suivantes en qualit\u00E9 d\u0027administrateurs de la Soci\u00E9t\u00E9, pour une dur\u00E9e de quatre (4) ans, avec effet imm\u00E9diat: oNew Breath SPRL, repr\u00E9sent\u00E9e par son repr\u00E9sentant permanent Monsieur Michel Vanbrabant, qui poursuit d\u00E8s lors \u00E9galement son mandat d\u0027administrateur-d\u00E9l\u00E9gu\u00E9 de la soc"
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Ekaterina Smirnyagina",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "Capricorn Venture Partners NV",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2019-09-02",
"evidence_quote": "de r\u00E9\u00E9lire les personnes suivantes en qualit\u00E9 d\u0027administrateurs de la Soci\u00E9t\u00E9, pour une dur\u00E9e de quatre (4) ans, avec effet imm\u00E9diat: oCapricorn Venture Partners NV, repr\u00E9sent\u00E9e par son repr\u00E9sentant permanent Madame Ekaterina Smirnyagina;"
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Marc Nolet de Brauwere van Steeland",
"address": null,
"birth_date": null
},
"effective_date": "2019-09-02",
"evidence_quote": "de r\u00E9\u00E9lire les personnes suivantes en qualit\u00E9 d\u0027administrateurs de la Soci\u00E9t\u00E9, pour une dur\u00E9e de quatre (4) ans, avec effet imm\u00E9diat: oMonsieur Marc Nolet de Brauwere van Steeland;"
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Marty Wax",
"address": null,
"birth_date": null
},
"effective_date": "2019-09-02",
"evidence_quote": "de r\u00E9\u00E9lire les personnes suivantes en qualit\u00E9 d\u0027administrateurs de la Soci\u00E9t\u00E9, pour une dur\u00E9e de quatre (4) ans, avec effet imm\u00E9diat: oMonsieur Marty Wax; et"
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "David Guyer",
"address": null,
"birth_date": null
},
"effective_date": "2019-09-02",
"evidence_quote": "de r\u00E9\u00E9lire les personnes suivantes en qualit\u00E9 d\u0027administrateurs de la Soci\u00E9t\u00E9, pour une dur\u00E9e de quatre (4) ans, avec effet imm\u00E9diat: oMonsieur David Guyer."
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Bram Vanparys",
"address": null,
"birth_date": null
},
"effective_date": "2019-09-02",
"evidence_quote": "de nommer avec effets imm\u00E9diats les personnes suivantes en qualit\u00E9 d\u0027administrateurs de la Soci\u00E9t\u00E9, pour une dur\u00E9e de quatre (4) ans: oMonsieur Bram Vanparys, n\u00E9 le 12 Novembre 1980 \u00E0 Veurne (Belgique), et domicili\u00E9 Scheldeoever 22, bo\u00EEte 10 \u00E0 2620 Hemiksem (Belgique);"
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Anne Portwich",
"address": null,
"birth_date": null
},
"effective_date": "2019-09-02",
"evidence_quote": "de nommer avec effets imm\u00E9diats les personnes suivantes en qualit\u00E9 d\u0027administrateurs de la Soci\u00E9t\u00E9, pour une dur\u00E9e de quatre (4) ans: oMadame Anne Portwich, n\u00E9e le 20 Octobre 1971 \u00E0 Kiel (Allemagne), et domicili\u00E9e Warmonderweg 26A \u00E0 2341 KW Oegstgeest (Pays-Bas);"
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Lionel Carnot",
"address": null,
"birth_date": null
},
"effective_date": "2019-09-02",
"evidence_quote": "de nommer avec effets imm\u00E9diats les personnes suivantes en qualit\u00E9 d\u0027administrateurs de la Soci\u00E9t\u00E9, pour une dur\u00E9e de quatre (4) ans: oMonsieur Lionel Carnot, n\u00E9 le 18 juin 1967 \u00E0 Neuilly-sur-Seine (France), et domicili\u00E9 Kastanienweg 44 \u00E0 3123 Belp (Suisse)"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0828.058.712",
"name_full": "ISTAR MEDICAL",
"legal_form": "SA"
}
}25-06-2019 1 director appointed, 1 resigning
- Michel Lussier, Bestuurder
- Michel Lussier, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Michel Lussier",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "Medpole SA",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2017-12-31",
"evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale prend,, \u00E0 toutes fins utiles, connaissance de la d\u00E9mission, \u00E0 compter du 31 d\u00E9cembre 2017, en qualit\u00E9 d\u0027administrateur de la Soci\u00E9t\u00E9, de Medpole SA, dont le si\u00E8ge social est \u00E9tabli Rue Edouard Belin 12 \u00E0 1435 Mont-Saint-Guibert, Belgique, et repr\u00E9sent\u00E9e par son repr\u00E9sentant perm"
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Michel Lussier",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "Mel Management SPRL",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2018-01-01",
"evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide de nommer, voire de confirmer la nomination, de Mel Management SPRL, dont le si\u00E8ge social est \u00E9tabli rue de Combreuil 3 \u00E0 7190 Ecaussines, Belgique, et repr\u00E9sent\u00E9e par son repr\u00E9sentant Monsieur Michel Lussier, en qualit\u00E9 d\u0027administrateur de la Soci\u00E9t\u00E9 et ce, \u00E0 compter du "
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0828.058.712",
"name_full": "ISTAR MEDICAL",
"legal_form": "SA"
}
}29-04-2019 Transaction in capital or shares
Technical details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0828.058.712",
"name_full": "ISTAR MEDICAL",
"legal_form": "SA"
}
}13-09-2018 Capital increase of €7,700,000 to €8,006,845.02
- €306.845,02 → €8.006.845,02
- 3 kapitaalbewegingen in deze akte
Technical details
{
"events": [
{
"kind": "capital_increase",
"amount": 7700000,
"currency": "EUR",
"after_eur": 8006845.02,
"delta_eur": 7700000.0,
"before_eur": 306845.02,
"amount_type": "kapitaal_toegestaan",
"effective_date": "2018-07-12",
"evidence_quote": "d\u0027augmenter le capital social de la Soci\u00E9t\u00E9, soit actuellement d\u0027un montant de trois cent six mille huit cent quarante-cing euros et deux cents (306.845,02 \u20AC) par incorporation de primes d\u0027\u00E9mission ... \u00E0 concurrence d\u0027un montant de sept millions sept cent mille euros (7.700.000 \u20AC), sur la base de ce qui est mentionn\u00E9 dans la situation active et passive de la Soci\u00E9t\u00E9 arr\u00EAt\u00E9e au trente-et-un mai deux mille dix-huit, pour porter le capital social de la Soci\u00E9t\u00E9 de trois cent six mille huit cent quarante-cing euros et deux cents (306.845.02 \u20AC) \u00E0 huit millions six mille huit cent quarante-cing euros et deux cents (8.006.845,02\u20AC)",
"contribution_type": "in_kind"
},
{
"kind": "capital_decrease",
"amount": 7700000,
"currency": "EUR",
"after_eur": 306845.02,
"delta_eur": -7700000.0,
"before_eur": 8006845.02,
"amount_type": "kapitaal_effectief",
"effective_date": "2018-07-12",
"evidence_quote": "l\u0027assembl\u00E9e d\u00E9cide de r\u00E9duire le capital social de la Soci\u00E9t\u00E9 \u00E0 concurrence d\u0027un montant de sept millions sept cent mille euros (7.700.000,00 \u20AC), pour le ramener d\u0027un montant de huit millions six mille huit cent quarante-cing euros et deux cents (8.006.845,02 \u20AC) \u00E0 un montant de trois cent six mille huit cent quarante-cing euros et deux cents (306.845.02 \u20AC), par apurement, par priorit\u00E9 sur le capital social lib\u00E9r\u00E9, des pertes report\u00E9es",
"contribution_type": "in_kind"
},
{
"kind": "capital_increase",
"amount": 3582.38,
"currency": "EUR",
"after_eur": 310427.4,
"delta_eur": 3582.38,
"before_eur": 306845.02,
"amount_type": "kapitaal_effectief",
"effective_date": "2018-07-12",
"evidence_quote": "L\u0027assembl\u00E9e constate la r\u00E9alisation effective de l\u0027augmentation du capital qui pr\u00E9c\u00E8de \u00E0 concurrence de trois mille cing cent quatre-vingt-deux euros et trente-huit cents (3.582,38 \u20AC) de sorte que le capital social de la Soci\u00E9t\u00E9 est effective-ment port\u00E9 de trois cent six mille huit cent quarante-cinq euros et deux cents (306.845,02 \u20AC) \u00E0 trois cent dix mille quatre cent vingt-sept euros et quarante cents (310.427,40 \u20AC)",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0828.058.712",
"name_full": "ISTAR MEDICAL",
"legal_form": "SA"
}
}04-12-2017 Mélanie Adorante reappointed as statutory auditor
- Mélanie Adorante, Commissaris
Technical details
{
"events": [
{
"kind": "commissaris_renew",
"role": "commissaris",
"person": {
"rrn": null,
"name": "M\u00E9lanie Adorante",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "SCCRL PwC R\u00E9viseurs d\u0027Entreprises",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "Conform\u00E9ment aux mentions reprises dans le cadre des d\u00E9l\u00E9gations de pouvoirs ayant fait l\u0027objet des r\u00E9solutions de l\u0027assembl\u00E9e g\u00E9n\u00E9rale extraordinaire de la Soci\u00E9t\u00E9 du 28 juin 2017, pr\u00E9cit\u00E9e, la SCCRL PwC R\u00E9viseurs d\u0027Entreprises, ayant son si\u00E8ge social \u00E0 1932 Sint-Stevens-Woluwe, Woluwedal 18, est r"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0828.058.712",
"name_full": "ISTAR MEDICAL",
"legal_form": "SA"
}
}22-08-2017 Capital increase
Technical details
{
"events": [
{
"kind": "capital_increase",
"amount": null,
"currency": "EUR",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"amount_type": "kapitaal_toegestaan",
"effective_date": "2017-06-28",
"evidence_quote": "Sous la condition suspensive et dans la mesure de l\u0027exercice des warrants \u00E9mis dans le cadre du Plan d\u0027Options sur Actions ou Plan de Warrants de Juin 2017, l\u0027assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide d\u0027augmenter le capital de la Soci\u00E9t\u00E9 \u00E0 concurrence d\u0027un montant maximum d\u00E9termin\u00E9 conform\u00E9ment aux termes et conditions desdits warrants",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0828.058.712",
"name_full": "ISTAR MEDICAL",
"legal_form": "SA"
}
}27-07-2017 Capital increase of €76,875 to €306,845.02
- €229.970,02 → €306.845,02
Technical details
{
"events": [
{
"kind": "capital_increase",
"amount": 76875,
"currency": "EUR",
"after_eur": 306845.02,
"delta_eur": 76875.0,
"before_eur": 229970.02,
"amount_type": "kapitaal_effectief",
"effective_date": "2017-06-28",
"evidence_quote": "Le capital social de la Soci\u00E9t\u00E9 sera d\u00E8s lors augment\u00E9 \u00E0 concurrence de septante six mille huit cent septante cing euros (76.875,- \u20AC) pour porter le capital social de la Soci\u00E9t\u00E9 de deux cent vingt-neuf mille neuf cent septante euros et deux cents (229.970,02 \u20AC) \u00E0 trois cent six mille huit cent quarante-cing euros et deux cents (306.845,02 \u20AC)",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0828.058.712",
"name_full": "ISTAR MEDICAL",
"legal_form": "SA"
}
}09-12-2016 Capital increase of €6,430,000 to €6,659,970.02
- €229.970,02 → €6.659.970,02
- 2 kapitaalbewegingen in deze akte
Technical details
{
"events": [
{
"kind": "capital_increase",
"amount": 6430000.0,
"currency": "EUR",
"after_eur": 6659970.02,
"delta_eur": 6430000.0,
"before_eur": 229970.02,
"amount_type": "kapitaal_effectief",
"effective_date": "2016-11-22",
"evidence_quote": "l\u0027assembl\u00E9e d\u00E9cide d\u0027augmenter le capital de la Soci\u00E9t\u00E9, soit actuellement d\u0027un montant de deux cent vingt-neuf mille neuf cent septante euros et deux cents (229.970,02 EUR) par incorporation de primes d\u0027\u00E9mission ... pour porter le capital social de la Soci\u00E9t\u00E9 de deux cent vingt-neuf mille neuf cent septante euros et deux cents (229.970,02 EUR) \u00E0 six millions six cent cinquante-neuf mille neuf cent septante euros et deux cents (6.659.970,02 EUR)",
"contribution_type": "in_kind"
},
{
"kind": "capital_decrease",
"amount": 6430000.0,
"currency": "EUR",
"after_eur": 229970.02,
"delta_eur": -6430000.0,
"before_eur": 6659970.02,
"amount_type": "kapitaal_effectief",
"effective_date": "2016-11-22",
"evidence_quote": "l\u0027assembl\u00E9e d\u00E9cide de r\u00E9duire le capital social de la soci\u00E9t\u00E9 \u00E0 concurrence de six millions quatre cent trente mille euros (6.430.000,00 EUR), pour le ramener d\u0027un montant de six millions six cent cinquante-neuf mille neuf cent septante euros et deux (6.659.970,02 eur) a deux cent vingt-neuf mille neuf cent septante euros et deux cents (229.970,02 EUR)",
"contribution_type": "in_kind"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0828.058.712",
"name_full": "ISTAR MEDICAL",
"legal_form": "SA"
}
}23-11-2016 4 directors appointed
- Martin Wax, Bestuurder
- Ekaterina Smirnyagina, Bestuurder
- Philippe Degive, Bestuurder
- Michel Vanbrabant, Bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Martin Wax",
"address": null,
"birth_date": null
},
"effective_date": "2016-06-01",
"evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide de nommer, voire de confirmer la nomination, de Monsieur Martin Wax M.D, domicili\u00E9 150 Morristown Avenue, Bernardsville, NJ 07924-2626, Etats-Unis d\u0027Am\u00E9rique, en qualit\u00E9 d\u0027administrateur de la Soci\u00E9t\u00E9 et ce, \u00E0 compter du 1er juin 2016."
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Ekaterina Smirnyagina",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "Capricorn Venture Partners NV",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2016-06-01",
"evidence_quote": "Capricorn Venture Partners NV, represent\u00E9e par son repr\u00E9sentant permanent Madame Ekaterina Smirnyagina;"
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Philippe Degive",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "Sparaxis SA",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2016-06-01",
"evidence_quote": "Sparaxis SA, represent\u00E9e par son repr\u00E9sentant permanent Monsieur Philippe Degive;"
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Michel Vanbrabant",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "New Breath SPRL",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2016-06-01",
"evidence_quote": "New Breath SPRL, represent\u00E9e par son repr\u00E9sentant permanent Monsieur Michel Vanbrabant."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0828.058.712",
"name_full": "ISTAR MEDICAL",
"legal_form": "SA"
}
}15-04-2016 7 reappointed
- Max Maginness, Bestuurder
- Michel Vanbrabant, Bestuurder
- Michel Lussier, Bestuurder
- Ekaterina Sminyagina, Bestuurder
- Philippe Degive, Bestuurder
- Marc Nolet de BRAUWERE van STEELAND, Bestuurder
- Michel Vanbrabant, Gedelegeerd bestuurder
Technical details
{
"events": [
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Max Maginness",
"address": null,
"birth_date": null
},
"evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide de r\u00E9\u00E9lire ou, \u00E0 d\u00E9faut, nommer en qualit\u00E9 d\u0027administrateurs avec effet imm\u00E9diat: 1/ Mr. Max Maginness (\u0022Administrateur Ordinaire\u0022);"
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Michel Vanbrabant",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "New Breath SPRL",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide de r\u00E9\u00E9lire ou, \u00E0 d\u00E9faut, nommer en qualit\u00E9 d\u0027administrateurs avec effet imm\u00E9diat: 2/ New Breath SPRL, repr\u00E9sent\u00E9e par son repr\u00E9sentant permanent Monsieur Michel Vanbrabant (\u0022CEO\u0022);"
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Michel Lussier",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "MedPole SA",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide de r\u00E9\u00E9lire ou, \u00E0 d\u00E9faut, nommer en qualit\u00E9 d\u0027administrateurs avec effet imm\u00E9diat: 3/MedPole SA, repr\u00E9sent\u00E9e par son repr\u00E9sentant permanent Monsieur Michel Lussier (\u0022Administrateur Ind\u00E9pendant\u0022);"
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Ekaterina Sminyagina",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "Capricorn Venture Partners NV",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide de r\u00E9\u00E9lire ou, \u00E0 d\u00E9faut, nommer en qualit\u00E9 d\u0027administrateurs avec effet imm\u00E9diat: 4/Capricorn Venture Partners NV, repr\u00E9sent\u00E9e par son repr\u00E9sentant permanent Madame Ekaterina Sminyagina);"
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Philippe Degive",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "Sparaxis SA",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide de r\u00E9\u00E9lire ou, \u00E0 d\u00E9faut, nommer en qualit\u00E9 d\u0027administrateurs avec effet imm\u00E9diat: 5/ Sparaxis SA, repr\u00E9sent\u00E9e par son repr\u00E9sentant permanent Monsieur Philippe Degive;"
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Marc Nolet de BRAUWERE van STEELAND",
"address": null,
"birth_date": null
},
"evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide de r\u00E9\u00E9lire ou, \u00E0 d\u00E9faut, nommer en qualit\u00E9 d\u0027administrateurs avec effet imm\u00E9diat: 6/ Monsieur Marc Nolet de BRAUWERE van STEELAND, domicili\u00E9 Avenue du Verger 35, \u00E0 1640 Rhode-Saint-Gen\u00E8se, Belgique."
},
{
"kind": "director_renew",
"role": "gedelegeerd_bestuurder",
"person": {
"rrn": null,
"name": "Michel Vanbrabant",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "New Breath SPRL",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "Suite \u00E0 leur r\u00E9\u00E9lection, l\u0027assembl\u00E9e g\u00E9n\u00E9rale constate que, compte tenu des termes de leur nomination en qualit\u00E9 d\u0027administrateur de la soci\u00E9t\u00E9: 2/ New Breath SPRL, repr\u00E9sent\u00E9e par son repr\u00E9sentant permanent Monsieur Michel Vanbrabant, poursuite son mandat de CEO (administrateur d\u00E9l\u00E9gu\u00E9) de la soci\u00E9"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0828.058.712",
"name_full": "ISTAR MEDICAL",
"legal_form": "SA"
}
}06-11-2015 Registered office moved from Isnes to Wavre
- rue Phocas Lejeune 25, 5032 Isnes → avenue Sabin 6, 1300 Wavre
Technical details
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "statutaire",
"new_address": {
"city": "Wavre",
"region": "R\u00E9gion wallonne",
"street": "avenue Sabin",
"country": "BE",
"postcode": "1300",
"box_number": null,
"street_number": "6"
},
"old_address": {
"city": "Isnes",
"region": "R\u00E9gion wallonne",
"street": "rue Phocas Lejeune",
"country": "BE",
"postcode": "5032",
"box_number": "3",
"street_number": "25"
},
"effective_date": "2015-10-01",
"evidence_quote": "Transfert du si\u00E8ge social, avec effet au 1er octobre 2015, confirmation du si\u00E8ge social de la rue Phocas Lejeune 25/3, Parc Cr\u00E9alys - B\u00E2timent Regain \u00E0 5032 Isnes vers l\u0027avenue Sabin 6 \u00E0 1300 Wavre."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0828.058.712",
"name_full": "ISTAR MEDICAL",
"legal_form": "SA"
}
}22-05-2015 Articles of association amended
Technical details
{
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"statute_change": {
"name_change": false,
"seat_change": false,
"object_change": false,
"effective_date": "2015-04-17",
"legal_form_change": false
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0828.058.712",
"name_full": "ISTAR MEDICAL",
"legal_form": "SA"
},
"signature_regime": null,
"special_mandates": [
{
"quote": "Tous pouvoirs ont \u00E9t\u00E9 conf\u00E9r\u00E9s aux mandataires sp\u00E9ciaux d\u00E9sign\u00E9s ci-apr\u00E8s, chacun d\u0027eux pouvant agir seul et avec pouvoir de subd\u00E9l\u00E9gation, afin notamment de modifier l\u0027inscription de la Soci\u00E9t\u00E9 aupr\u00E8s de la Banque Carrefour des Entreprises, de toute autre personne physique ou morale, de toute institution, de toute administration comp\u00E9tente et, de faire en g\u00E9n\u00E9ral tout ce qui est n\u00E9cessaire \u00E0 cet effet, conform\u00E9ment aux pr\u00E9sentes r\u00E9solutions. Sont ains\u00ED d\u00E9sign\u00E9s comme mandataires: ... Ma\u00EEtre St\u00E9phane ROBYNS DE SCHNEIDAUER, Ma\u00EEtre Virginie LESCOT, ou tout autre avocat de l\u0027Association d\u0027Avocats \u003C DLA Piper UK LLP \u003E dont les bureaux sont \u00E9tablis \u00E0 1050 Bruxeiles, avenue Louise, 106.",
"holder_kbo": null,
"holder_name": "DLA Piper UK LLP",
"scope_categories": [
"KBO",
"filing",
"publication"
],
"with_substitution": true
}
],
"governance_change": {
"admin_delegated_added": []
}
}05-01-2015 Capital increase of €40,998.98 to €153,095.02
- €112.096,04 → €153.095,02
Technical details
{
"events": [
{
"kind": "capital_increase",
"amount": 40998.98,
"currency": "EUR",
"after_eur": 153095.02,
"delta_eur": 40998.98,
"before_eur": 112096.04,
"amount_type": "kapitaal_effectief",
"effective_date": "2014-12-15",
"evidence_quote": "4\u00B0 Suite \u00E0 l\u0027\u00E9mission de treize mille trois cent trente-trois (13.333) nouvelles Actions Privil\u00E9gi\u00E9es de la Soci\u00E9t\u00E9, le capital a \u00E9t\u00E9 effectivement augment\u00E9 d\u0027un montant de quarante mille neuf cent nonante-neuf euros nonante-huit cent (40.998,98 EUR (exact 40.998,975 EUR). ... 8\u00B0 ... 5.1. Le capital est fix\u00E9 \u00E0 cent cinquante-trois mille nonante-cinq euros et deux cents (153.095,02 EUR).",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0828.058.712",
"name_full": "ISTAR MEDICAL",
"legal_form": "SA"
}
}| Legal nameFR | ISTAR MEDICAL |